Table 1.
Characteristics of study participants at their first clinical examination
| Characteristics | Total population (N = 6126) |
|---|---|
| Time before diagnosis/last visit (years) | 14.7 (7.6, 18.3) |
| Women (%) | 3787 (61.8) |
| Current smoker (%) | 1439 (23.5) |
| Antihypertensive treatment (%) | 1035 (16.9) |
| Anti-diabetic treatment† (%) | 240 (6.8) |
| Statin treatment† (%) | 575 (16.3) |
| Age (years) | 68.8 ± 8.9 |
| Glucose† (mg/dl) | 105.7 ± 24.2 |
| Cholesterol† (mg/dl) | 226.6 ± 37.2 |
| HDL cholesterol† (mg/dl) | 54.9 ± 15.6 |
| Systolic blood pressure (mmHg) | 139.3 ± 22.1 |
| Diastolic blood pressure (mmHg) | 73.9 ± 11.4 |
| Body mass index (kg/m2) | 26.3 ± 3.7 |
| Waist circumference (cm) | 90.0 ± 11.1 |
HDL high density lipoprotein, CVD cardiovascular disease, n number
* Values are mean ± SD, numbers (percentages), or median (IQR)
†Fasting measurements of Lipids and glucose and treatment were available in the third, fourth and fifth visits of the original Rotterdam Study cohort (N = 3529)